Small Molecule Inhibitor for Treatment of Obesity and Type 2 Diabetes


The use of small molecular inhibitor is a new and developing area of pharmaceutical interest for identifying and evluating mechanisms assciated with complex drug discovery pathways to treat obesity and type 2 diabetes.

This technology is available for exclusive licensing.

Download brochure